This study is the first to demonstrate that lncRNA LOC610012 inhibits CMT cell proliferation, migration, and invasion, as well as tumor growth in vivo, by regulating the PTGS2/EP3/GSK-3β axis. The gene discussed is PTGS2; the disease is neoplasm.